AFL
Updated: 12/10/2026, 02:40:57
Aflac Incorporated, operating through its various subsidiary companies, focuses on delivering supplementary health and life insurance policies. The firm's business activities are structured into two primary divisions: Aflac Japan and Aflac U.S. In Japan, the company offers a diverse range of insurance products, including coverage for cancer, medical expenses, income support for nursing care, and the distinct GIFT plan. This segment also provides traditional whole and term life insurance, along with savings-oriented plans like WAYS and child endowment products. Meanwhile, the Aflac U.S. division caters to the American market, furnishing policies that address cancer, accidents, short-term disability, critical illness, and hospital stays. Additionally, it provides dental, vision, long-term care, disability, and both term and whole life insurance options. Aflac distributes its comprehensive suite of products through multiple channels, which include dedicated sales associates, independent brokers, various corporate and individual agencies, and affiliated agencies. Established in 1955, the company maintains its corporate headquarters in Columbus, Georgia.
No summaries found.
Reported and calculated KPIs plus operational exposure disclosed in the FY 2025 filing.
Revenue
N/A
FY — · Reported
Net income
$3.6B
FY 2025 · Reported
Gross margin
N/A
FY — · Reported
Free cash flow
N/A
FY — · Reported
R&D intensity
N/A
FY — · Reported
Share repurchases
$3.5B
FY 2025 · Reported
Other offerings mentioned without separate sales
Area-level product sales are displayed only when the filing reports a product × geography breakdown. Regional totals are not allocated across products by estimation.
Map layer
Pins show disclosed operations. The heatmap colors the filing’s reported geographies; regional figures shade the region and are not estimates for each country.
Only locations and quantities explicitly supported by the filing are displayed. A country-level manufacturing percentage or product allocation is shown only when the source discloses it; materiality scores are never presented as production shares.
Core business
Aflac provides financial protection via supplemental health and life insurance in Japan and the U.S.; principal business is supplemental health and life insurance products
“The Company’s principal business is supplemental health and life insurance products with the goal to provide customers the best value in supplemental insurance products in Japan and the U.S.”
Licensing footprint
Authorized to conduct insurance business in all 50 states, D.C., several U.S. territories, and Japan
“The Company is authorized to conduct insurance business in all 50 states, the District of Columbia, several U.S. territories, and Japan.”
Japan revenue concentration
Aflac Japan's adjusted revenues were 53% of total adjusted revenues in 2025 (55% in 2024, 60% in 2023); 76% of total assets at Dec 31, 2025
“Aflac Japan's adjusted revenues accounted for 53% of the Company's total adjusted revenues in 2025, compared with 55% in 2024 and 60% in 2023. The percentage of the Company's total assets attributable to Aflac Japan was 76% at December 31, 2025”
U.S. shifting customer demographics
U.S. customer demographics shifting toward millennials and diverse cultural communities; aging baby boomers impact financial security and healthcare demand
“Customer demographics continue to shift, generating new opportunities across various consumer groups, including millennials and diverse cultural communities.”
Daido Life target customers
Cancer products offered to mainly small and medium-sized business owners, executives and employees via Daido Life
“offer Aflac Japan's cancer products to mainly small and medium-sized business owners, executives and employees”
Japan traditional sales channel
~6,300 sales agencies and ~112,000 licensed sales associates at end of 2025
“Aflac Japan was represented by approximately 6,300 sales agencies at the end of 2025, with approximately 112,000 licensed sales associates employed by those agencies”
Japan Post Group alliance
Japan Post alliance: ~20,000 postal outlets; Japan Post Insurance offers cancer products via 76 branches and 626 service departments
“approximately 20,000 postal outlets as of December 31, 2025. Japan Post Insurance Co., Ltd. (Japan Post Insurance) offers Aflac Japan's cancer products through its 76 branches responsible for corporate sales and 626 service departments in charge of individual sales.”
Japan bank channel
Agreements with approximately 90% of total banks in Japan to sell Aflac Japan's products at December 31, 2025
“At December 31, 2025, Aflac Japan had agreements with approximately 90% of the total number of banks in Japan to sell its products.”
Japan bank distribution channel
Agreements with 358 banks in Japan at Dec 31, 2025; bank sales represented 3.3% of Aflac Japan's new annualized premium sales in 2025
“the Company had agreements with 358 banks to market Aflac's products in Japan. Sales through these banks represented 3.3% of Aflac Japan's new annualized premium sales in 2025”
Dai-ichi Life alliance
Dai-ichi Life alliance (since 2001): ~37,000 representatives offer Aflac Japan's cancer products
“approximately 37,000 Dai-ichi Life representatives offer Aflac Japan's cancer products”
Daido Life alliance
Daido Life alliance (since 2013): ~3,700 representatives offering cancer products to SME owners, executives and employees
“approximately 3,700 Daido Life representatives offer Aflac Japan's cancer products to mainly small and medium-sized business owners, executives and employees”
Japan Post Group distribution dependency
Japan Post Group has accounted for a significant portion of Aflac Japan's total sales in recent periods
“its relationship with sales associates and other distribution partners, such as Japan Post Group, which in recent periods has accounted for a significant portion of Aflac Japan's total sales”
U.S. distribution model
U.S. commissioned sales force plus a salaried sales force of over 200 market directors and broker sales professionals; associates/brokers are independent contractors
“Aflac has expanded its sales leadership team to include a salaried sales force of over 200 market directors and broker sales professionals”
Japan protection-type life: Whole Life / GIFT
Whole Life (low cash surrender value, non-smoker discounts) and GIFT (monthly family-support term life)
“GIFT is a term life insurance product that provides beneficiaries, typically family members, with a fixed amount of money every month upon a breadwinner’s death or serious disability as family support.”
Japan savings-type life: Tsumitasu, WAYS, Child Endowment
Tsumitasu (launched June 2024), WAYS (conversion to medical/nursing/annuity), Child Endowment (educational benefits)
“Tsumitasu Launched in June 2024, Tsumitasu is an insurance product designed primarily for post-retirement preparation, with asset formation features and coverage for nursing care and other benefits.”
Product mix shift Japan third sector
Aflac Japan premium shift from first sector savings to third sector cancer/medical and first sector protection products
“the premium shift over recent years from first sector savings products to third sector cancer and medical products, as well as first sector protection products”
Aflac U.S. growth products
Aflac U.S. growth driven by life, disability, and dental and vision insurance products, which carry higher benefit ratios
“driven by growth in life, disability, and dental and vision insurance products, all of which typically carry higher benefit ratios”
Yen/dollar translation exposure
Yen/dollar fluctuations significantly affect reported results; a significant portion of business is conducted in yen and never converted into U.S. dollars
“Due to the size of Aflac Japan, where the functional currency is the Japanese yen, fluctuations in the yen/dollar exchange rate can have a significant effect on reported results.”
U.S. dollar-denominated investment strategy at Aflac Japan/Aflac Re
Aflac Japan holds USD-denominated investments across multiple asset classes to diversify from low JPY rates; hedged proportion reduced, increasing earnings volatility; Aflac Re USD investments exclusively investment-grade bonds
“the Company has reduced the proportion of U.S. dollar-denominated investments that are subject to a currency hedge, and this proportion continues to be subject to change at the Company’s discretion”
U.S. labor market and turnover risk
Aflac U.S. has experienced elevated workforce turnover amid tight labor market; sustained shortage could increase operating costs
“Although Aflac U.S. has not experienced any material labor shortage to date, it has experienced elevated levels of workforce turnover”
Japan competition intensified post-deregulation
Competition intensified since 2001 Japan deregulation; more insurers offering stand-alone cancer and medical insurance
“Since the deregulation of the Japan market in 2001, the number of insurance companies offering stand-alone cancer and medical insurance has increased, intensifying competition.”
Japan demographics demand driver
Japan's aging population and 100-year lifespans drive demand for supplemental health, asset formation, retirement and nursing care products
“With Japan’s aging population and the rise in healthcare costs, supplemental health care insurance products remain attractive. Additionally, as Japan enters an era of 100-year lifespans, customers' needs for asset formation and retirement coverage, including nursing care, are increasing.”
Japan third sector leadership
Aflac believes it will remain a leading provider of third sector cancer and medical insurance in Japan
“The Company believes Aflac Japan will remain a leading provider of third sector products such as cancer and medical insurance coverage in Japan, principally due to its experience in the market, well-known brand, low-cost operations, expansive marketing system and product expertise.”
Market-leading position and brand
Company defends and leverages market-leading position, powerful brand recognition and varied distribution in Japan and the U.S.
“while defending and leveraging its market-leading position, powerful brand recognition and varied distribution in Japan and the U.S.”
Growth strategy
Growth strategy: develop supplemental health products, complement of voluntary/employer-paid products, sell where customers prefer to buy
“The Company also offers a complement of other voluntary and employer-paid health and life insurance products to fit the needs of its customers.”
Capital deployment priorities
Maintain strong capital ratios in support of dividends; tactical capital deployment via share repurchases and opportunistic investments
“The Company intends to maintain strong capital ratios in Aflac Japan and Aflac U.S. in support of its commitment to shareholder dividends while remaining tactical in its deployment of capital in the form of share repurchases and opportunistic investments.”
Aflac Japan 2026 benefit and expense ratio guidance
2026 Aflac Japan guidance: benefit ratio 60%-63%, expense ratio 20%-23%
“the Company expects Aflac Japan to generate a benefit ratio in the range of 60% to 63% driven by favorable trends in morbidity experience, new product launches featuring lower benefit ratios, and the premium shift over recent years from first sector savings products to third sector cancer and medical products”
Aflac U.S. 2026 benefit and expense ratio guidance
2026 Aflac U.S. guidance: benefit ratio 48%-52%, expense ratio 36%-39%
“the Company expects Aflac U.S. to generate a benefit ratio in the range of 48% to 52% driven by growth in life, disability, and dental and vision insurance products”
2026 outlook and strategy
2026 objectives: preserve solid pretax profit margins, increased sales from 2025 Japan product launches, growth across both segments
“The Company's objectives in 2026 include preserving solid pretax profit margins with increased sales production achieved through the ongoing promotional efforts for products launched in 2025 in Aflac Japan and continued growth initiatives across both its Aflac Japan and Aflac U.S. segments.”
Corporate and other 2026 outlook
Corporate and other 2026: solid pretax adjusted earnings assuming stable U.S. rates; tax credit investment benefits recognized in lower income tax expense
“The Company's objectives for Corporate and other in 2026 include achieving solid pretax adjusted earnings, assuming that U.S. interest rates remain stable and excluding the impact of tax credit investments”
Dividend increase 5.2%
Board announced 5.2% quarterly cash dividend increase in November 2025, effective Q1 2026
“In November 2025, the board of directors announced a 5.2% increase in the quarterly cash dividend, effective with the first quarter of 2026.”
U.S. state insurance regulation
U.S. insurance subsidiaries subject to state insurance holding company regulation including prior notice/approval of dividends, transfers, and policy forms and rates
“certain dividend payments from insurance subsidiaries and certain transactions between companies within the system, including management fees, loans and advances are subject to prior notice to, or approval by, state regulatory authorities”
June 2025 cyber incident in U.S. business
June 2025 cyber incident: exfiltration of certain personal information relating to a substantial number of individuals in the U.S. business; not yet determined to have a reasonably likely material impact
“including the June 2025 cyber incident where the Company became aware of the exfiltration of certain personal information relating to a substantial number of customers, beneficiaries, employees, agents, and other individuals in the Company’s U.S. business”
Holding company dependency on subsidiary dividends
Parent Company depends on subsidiary transfers to meet debt service, common dividends, and buybacks; no assurance subsidiaries' earnings/assets will suffice
“Because the Parent Company conducts its operations through its operating subsidiaries, the Parent Company depends on those entities for dividends and other payments to generate the funds necessary to meet its debt service and other obligations”
Japan business concentration risk
Concentration in Japan and substantial JGB holdings expose company to Japan sovereign credit deterioration, market volatility, and low JPY reinvestment rates
“the Company has a substantial concentration of JGBs in its investment portfolio exposing the Company to credit deterioration and potential downgrades of JGBs”
AI heightens cybersecurity and business interruption risk
Use of AI by the Company and vendors could increase business interruption or cybersecurity breach risk; AI makes cyber-attacks more difficult to detect
“The rapid evolution and increased adoption of artificial intelligence technologies may also heighten the Company's cybersecurity risks by making cyber-attacks more difficult to detect, contain, and mitigate.”
Nebraska and Japan dividend restrictions on subsidiaries
Aflac (Nebraska) requires prior approval for dividends above greater of statutory net income from operations or 10% of statutory capital and surplus; Aflac Japan dividend capacity defined under FSA/Japanese corporate law criteria
“The Nebraska insurance statutes require prior approval for dividend distributions that exceed the greater of the net income from operations, which excludes net realized investment gains, for the previous year determined under statutory accounting principles, or 10% of statutory capital and surplus as of the previous year-end.”
Privacy and data security regulatory exposure
Regulated by APPI in Japan and HIPAA/state privacy laws in the U.S.; noncompliance could bring material fines, damages, FSA business improvement order, or license actions
“Under Japanese laws and regulations, including the APPI, if a leak or loss of personal information by Aflac Japan or its business associates should occur... Aflac Japan may be required to file reports to the FSA; issue public releases explaining such incident to the public; or become subject to an FSA business improvement order”
Extensive multi-jurisdiction regulation
Regulated by FSA/MOF in Japan, state insurance regulators, BMA in Bermuda, SEC, NAIC, DOJ, CFTC, and U.S. Treasury/IRS; compliance failures could trigger corrective action or ratings downgrades
“administered and enforced by a number of governmental authorities, that exercise a degree of interpretive latitude, including the FSA and Ministry of Finance (MOF) in Japan, state insurance regulators, the BMA in Bermuda, the SEC, the NAIC, the FIO”
Capital markets and economic sensitivity
Stressed or volatile global capital markets can adversely affect the Company's large investment portfolio, liabilities and derivatives
“Stressed conditions, volatility and disruptions in global capital markets, particular markets, or financial asset classes can have an adverse effect on the Company, in part because the Company has a large investment portfolio and its insurance liabilities and derivatives are sensitive to changing market factors.”
Tax rate change exposure in U.S. and Japan
Effective tax rate may differ from estimates due to Japan/U.S. earnings mix, tax audits, uncertain tax positions, and changes in U.S. or Japan tax laws
“Further, changes in U.S. or Japan tax laws or interpretations of such laws could increase the Company's corporate taxes and reduce earnings.”
Catastrophic event exposure
Catastrophic events (epidemics, natural disasters, war, terrorism) could cause claims volatility, lapse/premium grace-period effects, and impact 2026 Outlook guidance
“Claims resulting from natural or man-made catastrophic events could cause substantial volatility in the Company's financial results for any fiscal quarter or year and could materially reduce its profitability”
Third-party vendor operational risk
Reliance on third-party vendors for business support functions creates operational risk; certain vendors operate outside the U.S., exposing outsourced operations to foreign political and military events
“Since certain third-party vendors conduct operations for the Company outside the U.S., the political and military events in foreign jurisdictions could have an adverse impact on the Company’s outsourced operations.”
Monetary policy divergence including Bank of Japan
BoJ ended negative rates March 2024; yen-dollar rate differential contributes to FX hedging costs on Aflac Japan's USD investments
“The continuing difference between U.S. dollar and Japanese yen interest rates also contributes to costs of hedging foreign currency exchange risk of U.S. dollar-denominated investments held by Aflac Japan”
Competitive landscape in U.S. supplemental insurance
Profitability erosion at major medical carriers has led them to enter Aflac's supplemental segments, bundling and discounting products to gain market share
“given the profitability erosion some major medical carriers are facing in their core lines of business, the Company has seen a more competitive landscape as these carriers seek entry into Aflac's supplemental product segments”
Rating agency dependency constrains subsidiary dividend capacity
Subsidiary ability to pay dividends to Parent could be constrained by dependency on financial strength ratings from independent rating agencies
“The ability of Aflac and Aflac Japan to pay dividends or make other payments to the Parent Company could also be constrained by the Company's dependency on financial strength ratings from independent rating agencies.”
Model and risk management framework limitations
Enterprise risk management and models (pricing, reserves, valuation, capital) rely on uncertain assumptions; unanticipated morbidity/mortality/longevity/persistency could limit effectiveness
“In times of market stress, unanticipated market movements or unanticipated claims experience resulting from greater than expected morbidity, mortality, longevity, or persistency, the effectiveness of the Company's risk management strategies may be limited, resulting in losses to the Company.”
Climate change risk incorporated in credit review
Climate change risks are part of the credit review process and may adversely impact the value of securities held
“While the assessment of risks related to climate change are part of the Company's credit review process, climate change-related risks may adversely impact the value of the securities”
Counterparty/reinsurance exposure to Aflac Re
Aflac Japan reinsures to Aflac Re, which has less capital than external counterparties previously used
“Aflac Japan has entered into reinsurance transactions with Aflac Re, which has less capital than external counterparties with which the Company has conducted reinsurance transactions in the past”
Cybersecurity incident June 2025
Forward-looking risk cites uncertainty regarding impact of a June 2025 unauthorized network access incident
“uncertainty regarding the impact of the incident involving unauthorized access to the Company’s network in June 2025”
Aflac Japan generated 53% of adjusted revenues in 2025 and 76% of total assets; earnings tied to Japanese economy, JGBs, and yen exchange rate
“Aflac Japan's adjusted revenues accounted for 53% of the Company's total adjusted revenues in 2025”
Yen/dollar fluctuations materially affect reported earnings, cash flows and book value; yen weakening suppresses reported results.
“fluctuations in the yen/dollar exchange rate can have a significant effect on reported results”
Cyber incidents, including the June 2025 exfiltration event, can cause regulatory sanctions, litigation, remediation costs, and reputational damage affecting U.S. and Japan operations.
“the June 2025 cyber incident where the Company became aware of the exfiltration of certain personal information relating to a substantial number of customers, beneficiaries, employees, agents, and other individuals in the Company’s U.S. business”
Nebraska, FSA/Japanese, and Bermuda regulation restrict subsidiary dividend capacity to the Parent, affecting debt service, dividends, and buybacks.
“The FSA does not allow dividends or other payments from Aflac Japan unless it meets certain financial criteria as governed by Japanese corporate law.”
Japan's aging population and 100-year lifespans drive demand for supplemental health, asset formation, retirement and nursing care products in the Aflac Japan segment.
“With Japan’s aging population and the rise in healthcare costs, supplemental health care insurance products remain attractive.”
Japan Post Group is a major affiliated corporate agency distribution channel with ~20,000 postal outlets selling Aflac Japan's cancer products
“the number of postal outlets of Japan Post Co. Ltd. (Japan Post Co.) offering Aflac Japan's cancer product increased, with approximately 20,000 postal outlets as of December 31, 2025”
Japan Post Group has accounted for a significant portion of Aflac Japan's total sales in recent periods
“such as Japan Post Group, which in recent periods has accounted for a significant portion of Aflac Japan's total sales”
Business depends on technology systems for employers, policyholders, associates, and brokers; legacy systems require heavy investment, and IT transformation and cloud adoption increase cyber attack exposure.
“As the Company pursues IT transformation and increased cloud adoption, it inherently exposes the Company to potential cyber-related attacks.”
Large investment portfolio and market-sensitive insurance liabilities and derivatives expose results to capital market stress and volatility.
“Stressed conditions, volatility and disruptions in global capital markets... can have an adverse effect on the Company”
Premium shift from first sector savings to third sector cancer/medical products drives Japan benefit ratio outlook and 2026 sales growth.
“the premium shift over recent years from first sector savings products to third sector cancer and medical products, as well as first sector protection products”
USD-denominated investments at Aflac Japan/Aflac Re create unmatched FX exposure vs JPY liabilities; hedged proportion reduced, increasing earnings volatility
“Investing in U.S. dollar-denominated investments in Aflac Japan and Aflac Re creates an unmatched foreign currency exposure and related capital ratio volatility”
Rate differentials raise FX hedging costs; JGB values and JPY reinvestment rates sensitive to BoJ policy; rising rates also create Japan regulatory impairment risk
“The continuing difference between U.S. dollar and Japanese yen interest rates also contributes to costs of hedging foreign currency exchange risk”
AI adoption raises cybersecurity risk and the Company incurs expenses for AI development; AI also makes cyber-attacks harder to detect and mitigate.
“The Company will continue to incur expenses related to, among other things, investments in digital capabilities and product innovation including the development and use of artificial intelligence (AI).”
Dai-ichi Life's ~37,000 representatives distribute Aflac Japan's cancer products
“approximately 37,000 Dai-ichi Life representatives offer Aflac Japan's cancer products”
2001 deregulation increased number of insurers offering stand-alone cancer and medical insurance, intensifying competition
“Since the deregulation of the Japan market in 2001, the number of insurance companies offering stand-alone cancer and medical insurance has increased, intensifying competition.”
Cybersecurity incident created expense and potential future litigation, investigation, and elevated insurance premium costs.
“expenses arising from potential litigation, governmental investigations, or enforcement actions; ... elevated cybersecurity insurance premiums”
Banks are a key source of insurance solutions in Japan; Aflac Japan has agreements with ~90% of banks
“At December 31, 2025, Aflac Japan had agreements with approximately 90% of the total number of banks in Japan to sell its products.”
Changes in U.S. or Japan tax laws or interpretations, plus audit results and earnings mix, could raise the effective tax rate and reduce earnings.
“If the Company's effective tax rate were to increase, the Company's financial condition and results of operations could be adversely affected.”
Daido Life's ~3,700 representatives distribute cancer products to SME owners and executives
“Aflac Japan's alliance with Daido Life was launched in 2013, and approximately 3,700 Daido Life representatives offer Aflac Japan's cancer products”
Outsourced business support functions expose Aflac to vendor outages, cyber incidents, and foreign political/military disruptions affecting operations, revenues, and costs.
“The reliance on these third-party vendors creates a number of business risks, such as the risk that the Company may not maintain service quality, control or effective management of the outsourced business operations”
Growth in these higher benefit ratio products drives Aflac U.S. 2026 benefit ratio guidance of 48%-52% and revenue growth expected to reduce expense ratios over time.
“driven by growth in life, disability, and dental and vision insurance products, all of which typically carry higher benefit ratios”
ESR at 100% is the basis for supervisory intervention by Japanese authorities
“The ESR level, which is the basis for supervisory intervention by the authorities, is set at 100%.”
Japan FSA prescribes the SMR for all Japanese life insurers to measure ability to pay policyholder claims
“This insurance ratio is prescribed by the Japan Financial Services Agency (FSA) and is used for all life insurance companies in Japan”
Major medical carriers entering supplemental segments and bundling/discounting products to gain market share pressure Aflac U.S.
“leverage their core benefit offerings by bundling and discounting products in order to gain market share”
Catastrophes can cause claims volatility, premium grace periods, lapse-rate volatility, infrastructure disruption, and changes to 2026 Outlook guidance.
“These catastrophic events may cause changes to estimates of future earnings, capital deployment and other guidance the Company has provided to the markets in the 2026 Outlook section of Item 7. MD&A.”
Shifting U.S. demographics including millennials, diverse cultural communities and aging baby boomers create new product opportunities and demand.
“Customer demographics continue to shift, generating new opportunities across various consumer groups, including millennials and diverse cultural communities.”
Corporate and other 2026 pretax adjusted earnings outlook assumes U.S. interest rates remain stable.
“assuming that U.S. interest rates remain stable and excluding the impact of tax credit investments”
Bank channel (3.3% of Japan new annualized premium sales in 2025) exposed to financial institution health
“the Company had agreements with 358 banks to market Aflac's products in Japan. Sales through these banks represented 3.3% of Aflac Japan's new annualized premium sales in 2025”
Tight labor market and elevated turnover could increase Aflac U.S. operating costs and impair hiring/retention
“These conditions, together with higher levels of inflation may result in increased operating expenses”
See which prediction-market events move AFL, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
The “Duck Stock” Keeps Quietly Making Money for Shareholders
MarketBeat • STOCK • 11/06/2026, 09:45:16
Aflac Incorporated to Present at the Morgan Stanley U.S. Financials Conference
PRNewsWire • STOCK • 01/06/2026, 19:31:00
Future Dividend Kings - Part Two
Seeking Alpha • STOCK • 24/05/2026, 04:30:00
Aflac Raises 65.9B Yen in Japan Bond Market Amid Foreign Issuer Rush
Zacks Investment Research • STOCK • 21/05/2026, 14:51:07
5 Stocks to Watch From Prospering Accident & Health Insurance Industry
Zacks Investment Research • STOCK • 19/05/2026, 16:21:10
Here's Why You Should Keep Holding Aflac in Your Portfolio
Zacks Investment Research • STOCK • 14/05/2026, 15:11:19
Aflac: An Insurer To Buy After Impressive Q1 Results, Even As Valuation Rises
Seeking Alpha • STOCK • 06/05/2026, 04:23:50
Aflac Q1 Earnings Miss Estimates on Lower Investment Income
Zacks Investment Research • STOCK • 01/05/2026, 12:50:26
Aflac CEO Dan Amos on building an American success story
CNBC Television • STOCK • 30/04/2026, 19:30:02
Aflac Incorporated (AFL) Q1 2026 Earnings Call Transcript
Seeking Alpha • STOCK • 30/04/2026, 17:21:37
Aflac (AFL) Reports Q1 Earnings: What Key Metrics Have to Say
Zacks Investment Research • STOCK • 29/04/2026, 22:01:13
Aflac (AFL) Q1 Earnings and Revenues Miss Estimates
Zacks Investment Research • STOCK • 29/04/2026, 21:42:31
